Plasma clot lysis time and its association with cardiovascular risk factors in black Africans

Zelda de Lange1, Marlien Pieters, Johann C Jerling

  • 1Centre of Excellence for Nutrition, North-West University, Potchefstroom, South Africa.

Plos One
|November 13, 2012
PubMed

Insights

Cardiovascular disease risk factors are linked to clot lysis times (CLT) in Black Africans. Urban women showed longer CLT than rural women, suggesting potential ethnic differences in fibrinolysis.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) prevalence is rising in urbanizing Black African populations.
  • Limited data exist on fibrinolytic potential and CVD risk factors in this demographic.
  • Plasma clot lysis time (CLT) reflects fibrinolytic function, crucial for understanding CVD risk.

Purpose of the Study:

  • To investigate associations between CVD risk factors and CLT in Black Africans.
  • To compare CLT between rural and urban Black Africans, considering differing CVD risk profiles.
  • To explore potential ethnic variations in fibrinolysis compared to European populations.

Main Methods:

  • Cross-sectional analysis of 1000 rural and 1000 urban, apparently healthy Black South Africans (aged 35-60).
  • Assessment of associations between various CVD risk factors (PAI-1(act), BMI, HbA1c, triglycerides, metabolic syndrome, fibrinogen, CRP, HIV status, alcohol consumption) and CLT.
  • Comparison of CLT between urban and rural participants, stratified by sex.

Main Results:

  • Increased PAI-1(act), BMI, HbA1c, triglycerides, metabolic syndrome, fibrinogen, CRP, female sex, and positive HIV status were associated with longer CLT.
  • Habitual alcohol consumption was linked to shorter CLT.
  • Urban women exhibited longer CLT than rural women; no sex difference in CLT was observed between urban and rural men.

Conclusions:

  • CLT is associated with multiple CVD risk factors in Black Africans.
  • Observed differences in CLT associations compared to European populations suggest potential ethnic variations in fibrinolysis.
  • Urbanization's impact on CLT is modulated by traditional CVD risk factors and their prevalence in different communities.

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...